Davenport & Co’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,957
| Closed | -$147K | – | 1073 |
|
|
2023
Q2 | $147K | Sell |
6,957
-766
| -10% | -$16.2K | ﹤0.01% | 996 |
|
|
2023
Q1 | $208K | Sell |
7,723
-134
| -2% | -$3.61K | ﹤0.01% | 956 |
|
|
2022
Q4 | $278K | Sell |
7,857
-563
| -7% | -$19.9K | ﹤0.01% | 833 |
|
|
2022
Q3 | $1.9M | Buy |
8,420
+923
| +12% | +$208K | 0.02% | 361 |
|
|
2022
Q2 | $1.42M | Sell |
7,497
-156
| -2% | -$29.5K | 0.01% | 417 |
|
|
2022
Q1 | $1.91M | Sell |
7,653
-217
| -3% | -$54K | 0.01% | 397 |
|
|
2021
Q4 | $1.23M | Sell |
7,870
-4,713
| -37% | -$734K | 0.01% | 501 |
|
|
2021
Q3 | $2.52M | Buy |
12,583
+3,390
| +37% | +$679K | 0.02% | 345 |
|
|
2021
Q2 | $2.35M | Sell |
9,193
-224
| -2% | -$57.3K | 0.02% | 309 |
|
|
2021
Q1 | $2.5M | Buy |
9,417
+100
| +1% | +$26.5K | 0.02% | 258 |
|
|
2020
Q4 | $3.44M | Buy |
9,317
+1,614
| +21% | +$595K | 0.03% | 215 |
|
|
2020
Q3 | $1.88M | Sell |
7,703
-415
| -5% | -$101K | 0.02% | 253 |
|
|
2020
Q2 | $2.34M | Sell |
8,118
-167
| -2% | -$48.1K | 0.03% | 219 |
|
|
2020
Q1 | $1.69M | Sell |
8,285
-192
| -2% | -$39.2K | 0.02% | 231 |
|
|
2019
Q4 | $3.79M | Buy |
+8,477
| New | +$3.79M | 0.04% | 192 |
|